Biote Corp. (NASDAQ:BTMDW) General Counsel Mary Elizabeth Conlon Sells 10,867 Shares of Stock
Biote Corp. (NASDAQ:BTMDW) General Counsel Mary Elizabeth Conlon Sells 10,867 Shares of Stock
biote Corp. (NASDAQ:BTMDW – Get Rating) General Counsel Mary Elizabeth Conlon sold 10,867 shares of the business's stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $5.92, for a total transaction of $64,332.64. Following the transaction, the general counsel now owns 122,402 shares in the company, valued at $724,619.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
biote Corp.（納斯達克股票代碼：BTMDW — 獲取評級）總法律顧問瑪麗·伊麗莎白·康隆在4月4日星期二的交易中出售了該公司10,867股股票。該股票的平均售價爲5.92美元，總交易額爲64,332.64美元。交易完成後，總法律顧問現在擁有該公司122,402股股票，價值724,619.84美元。該交易已在向美國證券交易委員會提交的法律文件中披露，該文件可在以下網址查閱 這個超鏈接。
biote Trading Up 4.9 %
biote 交易量上漲 4.9%
Shares of BTMDW stock opened at $0.43 on Friday. The stock's 50-day moving average price is $0.51. biote Corp. has a 12 month low of $0.05 and a 12 month high of $1.23.
BTMDW股票週五開盤價爲0.43美元。該股的50天移動平均價格爲0.51美元。biote Corp. 創下12個月低點0.05美元，爲12個月高點1.23美元。
Hedge Funds Weigh In On biote
對沖基金在 biote 上佔據權力
A number of institutional investors have recently bought and sold shares of BTMDW. Cowen AND Company LLC purchased a new position in biote during the fourth quarter worth about $44,000. BBR Partners LLC purchased a new position in biote during the third quarter worth about $44,000. Diametric Capital LP purchased a new position in biote during the fourth quarter worth about $60,000. Jefferies Financial Group Inc. purchased a new position in biote during the fourth quarter worth about $75,000. Finally, Meteora Capital LLC raised its stake in biote by 3,889.3% during the fourth quarter. Meteora Capital LLC now owns 461,278 shares of the company's stock worth $138,000 after purchasing an additional 449,715 shares during the period.
許多機構投資者最近買入和賣出了BTMDW的股票。Cowen AND Company LLC在第四季度收購了biote的新職位，價值約44,000美元。BBR Partners LLC在第三季度收購了biote的新職位，價值約44,000美元。Diametric Capital LP在第四季度收購了biote的新頭寸，價值約6萬美元。傑富瑞金融集團公司在第四季度收購了biote的新頭寸，價值約7.5萬美元。最後，Meteora Capital LLC在第四季度將其在biote的股份增加了3,889.3％。Meteora Capital LLC在此期間又購買了449,715股股票後，現在擁有該公司461,278股股票，價值13.8萬美元。
biote Company Profile
biote 公司簡介
(Get Rating)
（獲取評分）
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.
biote Corp. 在激素優化領域從事醫學實踐建設業務。該公司爲獲得Biote認證的從業者提供了一個平臺，以優化患者激素、維生素和礦物質水平的不平衡，並開出生物同質激素療法和推薦膳食補充劑。
Featured Stories
精選故事
- Get a free copy of the StockNews.com research report on biote (BTMDW)
- What Factors Will Drive S&P 500 Performance This Year?
- 2 Beautiful Investments In A Growing Industry
- Hypercharge Networks: Up Triple Digits, But What's The Big Deal?
- 3 Reasons Why Apple's 30% Rally Has Legs
- 3 Reasons to Pick First Citizens Instead of First Republic Bank
- 免費獲取 StockNews.com 關於 biote 的研究報告 (BTMDW) 的副本
- 哪些因素將推動標準普爾500指數今年的表現？
- 成長型行業的2項漂亮投資
- Hypercharge Networks：上漲了三位數，但有甚麼大不了的？
- 蘋果30％的漲勢有長足的3個原因
- 選擇原住民而不是第一共和國銀行的3個理由
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.
接收 biote Daily 的新聞和收視率 -在下面輸入您的電子郵件地址，以通過Marketbeat.com的免費每日電子郵件時事通訊接收biote和相關公司最新新聞和分析師評級的簡明每日摘要。
譯文內容由第三人軟體翻譯。